Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001933414-26-000099 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 16, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
48,523
Total Value
$659,036.41
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jul 13, 2026 | Exercise/Conversion | 3,542 | $10.20 | $36,128.40 | 61,275 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 13, 2026 | Exercise/Conversion | 4,167 | $14.25 | $59,379.75 | 65,442 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 13, 2026 | Exercise/Conversion | 6,349 | $1.08 | $6,856.92 | 71,791 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 13, 2026 | Sale | 14,058 | $27.58 | $387,716.83 | 57,733 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 15, 2026 | Sale | 6,349 | $26.61 | $168,954.51 | 51,384 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jul 13, 2026 | Exercise/Conversion | 3,542 | $0.00 | $0.00 | 109,792 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jul 13, 2026 | Exercise/Conversion | 4,167 | $0.00 | $0.00 | 79,167 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jul 13, 2026 | Exercise/Conversion | 6,349 | $0.00 | $0.00 | 0 | Direct | โ | View Details |